PMBL are used to prevent acute, sub-acute, recurrent or chronic infections of the upper and lower airways and the bronchopulmonary tree, in addition to acute exacerbations in chronic obstructive pulmonary disease (COPD).
The PMBL, prepared from a large array of inactivated pathogenic bacteria via mechanical lysis, will be sold under the brand name Ismigen.
Lallemand specializes in yeast, bacteria and yeast derivatives, for animal nutrition, baking, winemaking and pharmaceutical industries.